144 related articles for article (PubMed ID: 30344797)
1. Preserved miR-361-3p Expression Is an Independent Prognostic Indicator of Favorable Survival in Cervical Cancer.
Liu S; Song L; Yao H; Zhang L; Xu D; Li Q; Li Y
Dis Markers; 2018; 2018():8949606. PubMed ID: 30344797
[TBL] [Abstract][Full Text] [Related]
2. MiR-362-3p is downregulated by promoter methylation and independently predicts shorter OS of cervical squamous cell carcinoma.
Song L; Liu S; Yao H; Zhang L; Li Y; Xu D; Li Q
Biomed Pharmacother; 2019 Jul; 115():108944. PubMed ID: 31082771
[TBL] [Abstract][Full Text] [Related]
3. miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor suppressor by targeting YAP1.
Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
Cancer Biomark; 2019; 25(1):1-10. PubMed ID: 31006663
[TBL] [Abstract][Full Text] [Related]
4. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
Li M; Li BY; Xia H; Jiang LL
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
[TBL] [Abstract][Full Text] [Related]
5. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
6. SRSF3-regulated miR-132/212 controls cell migration and invasion by targeting YAP1.
Kim HR; Hwang SJ; Shin CH; Choi KH; Ohn T; Kim HH
Exp Cell Res; 2017 Sep; 358(2):161-170. PubMed ID: 28624413
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
8. MiR-216a-3p suppresses the proliferation and invasion of cervical cancer through downregulation of ACTL6A-mediated YAP signaling.
Zhao J; Li L; Yang T
J Cell Physiol; 2020 Dec; 235(12):9718-9728. PubMed ID: 32401366
[TBL] [Abstract][Full Text] [Related]
9. miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.
Pan Y; Robertson G; Pedersen L; Lim E; Hernandez-Herrera A; Rowat AC; Patil SL; Chan CK; Wen Y; Zhang X; Basu-Roy U; Mansukhani A; Chu A; Sipahimalani P; Bowlby R; Brooks D; Thiessen N; Coarfa C; Ma Y; Moore RA; Schein JE; Mungall AJ; Liu J; Pecot CV; Sood AK; Jones SJ; Marra MA; Gunaratne PH
Oncotarget; 2016 May; 7(18):25930-48. PubMed ID: 27036018
[TBL] [Abstract][Full Text] [Related]
10. Transferrin receptor-involved HIF-1 signaling pathway in cervical cancer.
Xu X; Liu T; Wu J; Wang Y; Hong Y; Zhou H
Cancer Gene Ther; 2019 Nov; 26(11-12):356-365. PubMed ID: 30651591
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-142-3p inhibits cell proliferation and invasion of cervical cancer cells by targeting FZD7.
Deng B; Zhang Y; Zhang S; Wen F; Miao Y; Guo K
Tumour Biol; 2015 Sep; 36(10):8065-73. PubMed ID: 25976503
[TBL] [Abstract][Full Text] [Related]
12. MiR-4653-3p and its target gene FRS2 are prognostic biomarkers for hormone receptor positive breast cancer patients receiving tamoxifen as adjuvant endocrine therapy.
Zhong X; Xie G; Zhang Z; Wang Z; Wang Y; Wang Y; Qiu Y; Li L; Bu H; Li J; Zheng H
Oncotarget; 2016 Sep; 7(38):61166-61182. PubMed ID: 27533459
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of miR-1254 is associated with cancer aggressiveness and predicts poor outcome in cervical cancer.
Zhou J; Liu X; Wang CH; Wang D; Du JJ
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2997-3001. PubMed ID: 29863243
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-519d-3p Inhibits Proliferation and Promotes Apoptosis by Targeting HIF-2α in Cervical Cancer Under Hypoxic Conditions.
Jiang L; Shi S; Shi Q; Zhang H; Xia Y; Zhong T
Oncol Res; 2018 Aug; 26(7):1055-1062. PubMed ID: 29321085
[TBL] [Abstract][Full Text] [Related]
15. Loss of MiR-424-3p, not miR-424-5p, confers chemoresistance through targeting YAP1 in non-small cell lung cancer.
Zhang M; Zeng J; Zhao Z; Liu Z
Mol Carcinog; 2017 Mar; 56(3):821-832. PubMed ID: 27500472
[TBL] [Abstract][Full Text] [Related]
16. Effects of microRNA-183 on epithelial-mesenchymal transition, proliferation, migration, invasion and apoptosis in human pancreatic cancer SW1900 cells by targeting MTA1.
Lin X; Zheng L; Song H; Xiao J; Pan B; Chen H; Jin X; Yu H
Exp Mol Pathol; 2017 Jun; 102(3):522-532. PubMed ID: 28506766
[TBL] [Abstract][Full Text] [Related]
17. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
[TBL] [Abstract][Full Text] [Related]
18. MiR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma.
Wang D; Wang H; Li Y; Li Q
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29871972
[TBL] [Abstract][Full Text] [Related]
19. The effects of Micro-429 on inhibition of cervical cancer cells through targeting ZEB1 and CRKL.
Wang Y; Dong X; Hu B; Wang XJ; Wang Q; Wang WL
Biomed Pharmacother; 2016 May; 80():311-321. PubMed ID: 27133071
[TBL] [Abstract][Full Text] [Related]
20. Role of miR-337-3p and its target Rap1A in modulating proliferation, invasion, migration and apoptosis of cervical cancer cells.
Cao XM
Cancer Biomark; 2019; 24(3):257-267. PubMed ID: 30883336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
